Nieuws en video's

EQS-News: 2G Energy AG / Key word(s): Incoming Orders/Dividend 2G Energy AG boosts order intake by 26% in 1st quarter 18.04.2024 / 13:04 CET/CEST The issuer is solely responsible for the content of this announcement. 2G Energy AG boosts order intake by 26% in 1st quarter Orders reach EUR 51.7 million (previous year: EUR 41.0 million) US market overcomes caution and shows significant growth (EUR 10.1 million; previous year: EUR 2.6 million) 2G sells its first CHP/heat pump combination in Germany...

EQS-News: 2G Energy AG / Schlagwort(e): Auftragseingänge/Dividende 2G Energy AG steigert Auftragseingang im 1. Quartal um 26% 18.04.2024 / 13:04 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. 2G Energy AG steigert Auftragseingang im 1. Quartal um 26% Auftragseingang erreicht 51,7 Mio. Euro (Vj.: 41,0 Mio. Euro) US-Markt überwindet Zurückhaltung und zeigt spürbares Wachstum (10,1 Mio. Euro; Vj.: 2,6 Mio. Euro) 2G verkauft in Deutschland die erste...

Veeva Launches AI Partner Program PR Newswire PLEASANTON, Calif., April 18, 2024 Advanced technology and support to enable the development of GenAI solutions PLEASANTON, Calif. , April 18, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced the Veeva AI Partner Program to provide partners with the advanced technology and support needed to integrate Generative AI (GenAI) solutions seamlessly with Veeva Vault applications. "Our customers are exploring GenAI solutions across many use...

Iridium Announces First-Quarter 2024 Results PR Newswire MCLEAN, Va., April 18, 2024 – Completes acquisition of Satelles, Inc., its first ever acquisition, on April 1 MCLEAN, Va. , April 18, 2024 /PRNewswire/ -- Iridium Communications Inc. (Nasdaq:IRDM) ("Iridium"), a leading provider of global voice and data satellite communications, today reported financial results for the first quarter of 2024 and reiterated its full-year 2024 outlook. Net income was $19 .7 million, or $0.16 per diluted...

Total Revenue Doubled with 100% Y/Y Growth from March of last year March Self-Mining Business Revenue up 182% Y/Y March Co-Location Business Revenue up 54% Y/Y March Total Revenue of about $5.44 million MIDLAND, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Mawson Infrastructure Group Inc. (NASDAQ:MIGI) (“Mawson” or the “Company”), a digital infrastructure company, announced today its unaudited business and operational update for March 2024. Rahul Mewawalla, CEO and President, commented, “We...

STAMFORD, Conn., April 18, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today announced that it will host a live conference call and webcast at 8:30 a.m. E.T. on Thursday, May 2, 2024 to report its first quarter financial results and discuss recent business updates. To join the live webcast and view the corresponding slides, please click here . To access the live call by phone,...

Emittent / Herausgeber: CureVac / Schlagwort(e): Sonstiges CureVac veröffentlicht am 24. April 2024 Finanzergebnisse des vierten Quartals sowie des Gesamtjahres 2023 und informiert über seine Geschäftsentwicklung 18.04.2024 / 13:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. CureVac veröffentlicht am 24. April 2024 Finanzergebnisse des vierten Quartals sowie des Gesamtjahres 2023 und informiert über seine Geschäftsentwicklung TÜBINGEN,...

Issuer: CureVac / Key word(s): Miscellaneous CureVac to Report Fourth Quarter and Full-Year 2023 Financial Results and Business Update on April 24, 2024 18.04.2024 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac to Report Fourth Quarter and Full-Year 2023 Financial Results and Business Update on April 24, 2024 TÜBINGEN, Germany/BOSTON, USA – April 18, 2024 – CureVac N.V. (Nasdaq: CVAC) (“CureVac”), a global biopharmaceutical company...

Fiscal 2023 Marks a Return to Organic Revenue Growth and Positive EBITDA ( 1) Record Breaking Backlog of US$7.0 million, Almost Doubling the Prior Year Performance Q1 of Fiscal 2024 Expected to Show Strong Revenue Growth TSXV: OML OTCQX: OLNCF LOS ANGELES, CALIFORNIA, April 18, 2024 (GLOBE NEWSWIRE) -- Omni-Lite Industries Canada Inc. (the "Company" or “Omni-Lite”; TSXV: OML) today reported results for the fourth quarter and fiscal year ending December 31, 2023. Full financial results are...

ATLANTA, April 18, 2024 (GLOBE NEWSWIRE) -- First Advantage Corporation (NASDAQ: FA), a leading provider of employment background screening, identity, and verification solutions, will issue its first quarter 2024 financial results on Thursday, May 9, 2024 prior to the Company’s earnings conference call, which will be held at 8:30 a.m. ET on the same day. Conference Call Details To participate in the conference call, please dial 800-343-4136 (domestic) or 203-518-9843 (international)...

NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today announces a platform presentation titled, “Treatment of PIRA with Nasal Foralumab Dampens Microglial Activation and Stabilizes Clinical Progression in Non-Active Secondary Progressive MS” at the Annual Meeting of the American Academy of Neurology in...

TORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders, announced today that the U.S. Food & Drug Administration (“FDA”) has accepted the Company’s meeting request for the Revive LC POC Lateral Flow Test Kit (the...

SHANGHAI, China, April 18, 2024 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility technology provider, today announced a strategic partnership with China FAW Group Co., Ltd. (“FAW Group”), China’s leading automaker, to develop next-generation intelligent cockpits for the premium Hongqi brand of vehicles. ECARX and FAW will combine their considerable research and development capabilities and technological strengths to build an...

Listing: TSX (Toronto Stock Exchange) Symbol : CBH, CBO, CDZ, CEW, CLF, CLG, CMR, CPD, CUD, CVD, CYH, FIE, XAGG, XAGG.U, XAGH, XBB, XCB, XCBG, XCBU, XCBU.U, XDG, XDG.U, XDGH, XDIV, XDU, XDU.U, XDUH, XDV, XEB, XEI, XFLB, XFN, XFR, XGB, XHB, XHD, XHU, XHY, XIG, XIGS, XLB, XPF, XQB, XRE, XSAB, XSB, XSC, XSE, XSH, XSHG, XSHU, XSHU.U, XSI, XSTB, XSTH, XSTP, XSTP.U, XTLH, XTLT, XTLT.U, XTR, XUT Listing: Cboe Canada (NEO Exchange Inc.) Symbol : XGGB TORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- BlackRock...

HOUSTON, April 18, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced completion of the second dose cohort of the dose escalation portion of its Phase 1/1b clinical trial of BP1002 evaluating the ability of BP1002 to treat refractory/relapsed acute myeloid leukemia (AML) patients, including...

HAYWARD, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace” DNA-directed RNA interference (“ddRNAi”) platform, today announced a $40.0 million private investment in public equity (PIPE) financing from the sale of 5,749,152 shares of its common stock at a price per share of $4.80,...

TORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX: XAM, TSX: XAM ) ( Xanadu, XAM or the Company ) is pleased to announce that it has engaged Bacchus Capital Advisers Limited ( Bacchus ) as its strategic and project funding adviser in relation to the Kharmagtai Copper-Gold Project in the South Gobi region of Mongolia. Highlights Xanadu is executing a Pre-Feasibility Study ( PFS ) at its Kharmagtai copper-gold project, a 50-50 joint venture with Zijin Mining Group Co Ltd ( Zijin )....

—Longitudinal Study of a 200+ Real-World Patient Cohort Further Validates CCL24 as a Novel Target for Systemic Sclerosis (SSc), Showing that It is Associated with Disease Severity Across the Fibrotic and Vascular Manifestations of SSc— TEL AVIV, Israel, April 18, 2024 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical stage biotechnology company developing innovative therapeutics to treat rare fibro-inflammatory diseases with high unmet need, today...

CHICAGO, April 18, 2024 (GLOBE NEWSWIRE) -- LanzaTech Global, Inc. (Nasdaq: LNZA) (“LanzaTech” or the “Company”), the carbon recycling company transforming waste carbon into sustainable raw materials, today announced that it will issue its first quarter 2024 financial results before the market opens on Thursday, May 9, 2024. A conference call will be held that same day at 8:30 A.M. ET to review the Company's financial results, discuss recent events and conduct a question-and-answer...

Paralyzed Veterans of America receives $1.17 million donation from Penske Automotive Group and celebrates 10th year of partnership PR Newswire WASHINGTON, April 18, 2024 WASHINGTON , April 18, 2024 /PRNewswire/ -- Paralyzed Veterans of America proudly celebrates a decade-long partnership with long-time supporter Penske Automotive Group , who donated $1.17 million in 2023 to the nonprofit to support paralyzed veterans nationwide. The amount is composed of donations from generous customers and...